Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
447 Molecular and immunological characterization of anti-PD-L1 response in GEMM-derived melanoma cell lines
- 1Brigham and Women’s Hospital, Boston, MA, USA
- 2Jingdezhen City Hospital of Traditional Chinese Medicine, Jingdezhen, China
- 3The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China
Related
- Microbiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma
- Novel Copper (II) Complex Derived from Sulfadiazine Azo Resorcinol Ligand: Characterization, Antibacterial Evaluation, and Molecular Docking Study.
- Omics-derived signatures in metabolic dysfunction-associated steatotic liver disease: from molecular characterization to clinical translation.
- Peripheral molecular signatures of major depressive disorder: a systematic review of blood-derived biomarkers for diagnosis, stratification, and treatment response.
- 1076 Patient-derived organoids reveal tumor-restricted noncanonical HLA-I antigen candidates in low mutation burden metastatic melanoma
BibTeX
@article{kupper2026molecular,
title = {{447 Molecular and immunological characterization of anti-PD-L1 response in GEMM-derived melanoma cell lines}},
author = {Thomas Küpper and Jiang Zhang and Shiyi Wang and Jason B Williams and Alexander Kley and Bharat Ashok Rajmalani and Kyle Deans and Hirien Modi},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0447},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0447},
note = {CC BY},
}
RIS
TY - JOUR
TI - 447 Molecular and immunological characterization of anti-PD-L1 response in GEMM-derived melanoma cell lines
AU - Thomas Küpper
AU - Jiang Zhang
AU - Shiyi Wang
AU - Jason B Williams
AU - Alexander Kley
AU - Bharat Ashok Rajmalani
AU - Kyle Deans
AU - Hirien Modi
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0447
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0447
SN - 2051-1426
ER -